Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients
U Krumsdorf, S Ostermayer, K Billinger… - Journal of the American …, 2004 - jacc.org
Objectives: The purpose of this study was to investigate the incidence, morphology, and
clinical course of thrombus formation after catheter closure of intra-atrial shunts …
clinical course of thrombus formation after catheter closure of intra-atrial shunts …
[HTML][HTML] Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular …
Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism
C Pristipino, H Sievert, F D'ascenzo… - European Heart …, 2019 - academic.oup.com
The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …
of medical conditions; however, the subject remains controversial and no official statements …
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
H Krum, M Schlaich, R Whitbourn, PA Sobotka… - The Lancet, 2009 - thelancet.com
Background Renal sympathetic hyperactivity is associated with hypertension and its
progression, chronic kidney disease, and heart failure. We did a proof-of-principle trial of …
progression, chronic kidney disease, and heart failure. We did a proof-of-principle trial of …
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
DR Holmes, VY Reddy, ZG Turi, SK Doshi, H Sievert… - The Lancet, 2009 - thelancet.com
Background In patients with non-valvular atrial fibrillation, embolic stroke is thought to be
associated with left atrial appendage (LAA) thrombi. We assessed the efficacy and safety of …
associated with left atrial appendage (LAA) thrombi. We assessed the efficacy and safety of …
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the …
DR Holmes, S Kar, MJ Price, B Whisenant… - Journal of the American …, 2014 - jacc.org
Abstract Background: In the PROTECT AF (Watchman Left Atrial Appendage Closure
Technology for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated …
Technology for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated …
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral …
… by: the European Stroke Organisation (ESO … - European heart …, 2011 - academic.oup.com
Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval …
F Maisano, O Franzen, S Baldus, U Schäfer… - Journal of the American …, 2013 - jacc.org
Objectives: The purpose of this article is to report early and mid-term outcomes of the
ACCESS-EU study (ACCESS-Europe A Two-Phase Observational Study of the MitraClip …
ACCESS-EU study (ACCESS-Europe A Two-Phase Observational Study of the MitraClip …
Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial
VY Reddy, H Sievert, J Halperin, SK Doshi… - Jama, 2014 - jamanetwork.com
Importance While effective in preventing stroke in patients with atrial fibrillation (AF), warfarin
is limited by a narrow therapeutic profile, a need for lifelong coagulation monitoring, and …
is limited by a narrow therapeutic profile, a need for lifelong coagulation monitoring, and …
Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With …
VY Reddy, S Möbius-Winkler, MA Miller… - Journal of the American …, 2013 - jacc.org
Objectives: The purpose of this study was to assess the safety and efficacy of left atrial
appendage (LAA) closure in nonvalvular atrial fibrillation (AF) patients ineligible for warfarin …
appendage (LAA) closure in nonvalvular atrial fibrillation (AF) patients ineligible for warfarin …